You have 9 free searches left this month | for more free features.

City

Houston (2)

Philadelphia (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (3)

Sponsor

M.D. Anderson Cancer Center (2)

Abramson Cancer Center of the University of Pennsylvania (1)

Collaborator

Xencor, Inc. (2)

Bayer (1)

Intervention

xmab20717 (3)

regorafenib (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (3)

Study Type

Interventional (3)

xmab20717

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Colorectal Cancer, Colon Cancer, Rectum Cancer Trial in Houston (Regorafenib, XmAb20717)

Not yet recruiting

Colorectal Cancer
+2 more

Regorafenib
XmAb20717

Houston, Texas

M D Anderson Cancer Center

May 31, 2023

Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)

Recruiting

Microsatellite High Cancers
+7 more

XmAb20717

Houston, Texas

M D Anderson Cancer Center

Aug 8, 2022

Biliary Tract Cancer Trial in Philadelphia (XmAb20717)

Recruiting

Biliary Tract Cancer

XmAb20717

Philadelphia, Pennsylvania

Abramson Cancer Center at University of Pennsylvania

Apr 11, 2022